David Liebner, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Niraparib for the Treatment of Leiomyosarcoma (NCT05174455) | David Liebner, MD | 2023-12-01 |
Track David Liebner, MD automatically
Every clearance here is in the API, with alerts when new ones post.